ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indonesia authorizes emergency use of China's mRNA vaccine

Country also adopts homegrown jab as it looks to build local production

Boxes of Walvax Biotechnology's mRNA vaccine for COVID-19 are displayed at a trade fair in Shanghai in April 2021, during the long development and trial process.   © China Daily via Reuters

JAKARTA/SHANGHAI -- Indonesia's drug regulator on Friday announced it had authorized the emergency use of China's AWcorna COVID-19 vaccine, becoming the first known country to approve a Chinese mRNA jab.

Penny Lukito, head of the Food and Drug Monitoring Agency, known as BPOM, said studies had shown that AWcorna's overall efficacy against the coronavirus reached 83.58% -- and 71.17% against the highly infectious omicron variant.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more